|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.76 HKD | +1.85% |
|
-6.00% | -10.58% |
| 02-10 | New purchases in the Asia-Pacific Investor portfolio |  |
| 01-26 | Jefferies Adjusts Giant Biogene's Price Target to HK$50 From HK$55, Keeps at Buy | MT |
| Capitalization | 27.39B 31.02B 3.97B 3.41B 3.1B 2.97B 5.42B 366B 5.62B 36.38B 14.57B 174B 14.9B 14.58B 623B | P/E ratio 2025 * |
13x | P/E ratio 2026 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise value | 21.41B 24.25B 3.1B 2.67B 2.42B 2.32B 4.24B 286B 4.39B 28.43B 11.38B 136B 11.64B 11.39B 487B | EV / Sales 2025 * |
3.62x | EV / Sales 2026 * | 2.97x |
| Free-Float |
42.68% | Yield 2025 * |
4.16% | Yield 2026 * | 4.32% |
| 1 day | +1.85% | ||
| 1 week | -6.00% | ||
| Current month | -6.77% | ||
| 1 month | -11.80% | ||
| 3 months | -22.30% | ||
| 6 months | -49.13% | ||
| Current year | -10.58% |
| 1 week | 28.96 |  | 32.2 |
| 1 month | 28.96 | | 34.78 |
| Current year | 28.96 | | 38 |
| 1 year | 28.96 | | 87.1 |
| 3 years | 28.4 | | 87.1 |
| 5 years | 24.3 | | 87.1 |
| 10 years | 24.3 | | 87.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ya Yan
CEO | Chief Executive Officer | 59 | 21/04/2022 |
Hui Juan Zhang
DFI | Director of Finance/CFO | 39 | 21/04/2022 |
Yu Bo Yan
SEC | Corporate Secretary | 30 | 01/10/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Ya Yan
CHM | Chairman | 59 | 21/04/2022 |
Juan Ye
BRD | Director/Board Member | 55 | 30/11/2021 |
Jin Huang
BRD | Director/Board Member | 67 | 06/10/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.85% | -6.00% | -57.06% | -37.35% | 3.97B | |
| -0.89% | -3.12% | -8.59% | +12.31% | 368B | |
| -0.71% | -5.30% | -0.55% | +9.88% | 149B | |
| -0.24% | -1.44% | +4.63% | +28.84% | 76.37B | |
| -0.28% | -5.38% | +3.90% | -9.25% | 63.4B | |
| +0.51% | -12.14% | +45.70% | -60.82% | 35.89B | |
| +0.22% | -3.09% | -22.33% | - | 34.87B | |
| -1.16% | -21.53% | -39.42% | -25.24% | 21.28B | |
| -0.71% | -7.30% | -12.35% | -5.11% | 19.85B | |
| -0.45% | -8.62% | +14.23% | +23.66% | 12.63B | |
| Average | -0.03% | -7.68% | -7.18% | -7.01% | 78.51B | |
| Weighted average by Cap. | -0.28% | -4.67% | -3.71% | +6.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.92B 6.7B 858M 737M 669M 642M 1.17B 79.05B 1.21B 7.86B 3.15B 37.7B 3.22B 3.15B 135B | 6.89B 7.81B 998M 859M 779M 747M 1.36B 92.05B 1.41B 9.15B 3.66B 43.9B 3.75B 3.67B 157B |
| Net income | 2.12B 2.4B 307M 264M 240M 230M 419M 28.3B 435M 2.81B 1.13B 13.49B 1.15B 1.13B 48.2B | 2.4B 2.72B 348M 299M 272M 261M 476M 32.11B 493M 3.19B 1.28B 15.31B 1.31B 1.28B 54.68B |
| Net Debt | -5.98B -6.77B -867M -745M -676M -649M -1.18B -79.88B -1.23B -7.94B -3.18B -38.1B -3.25B -3.18B -136B | -6.9B -7.81B -999M -859M -780M -748M -1.37B -92.12B -1.41B -9.16B -3.67B -43.93B -3.75B -3.67B -157B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 29.76 $ | +1.85% | 4,141,035 |
| 04/03/26 | 29.22 $ | -3.05% | 8,473,141 |
| 03/03/26 | 30.14 $ | -3.64% | 6,765,230 |
| 02/03/26 | 31.28 $ | -2.01% | 5,600,899 |
| 27/02/26 | 31.92 $ | +0.82% | 3,812,677 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2367 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition